Semi-elemental versus polymeric formula for enteral nutrition in brain-injured critically ill patients: a randomized trial.


Journal

Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902

Informations de publication

Date de publication:
20 01 2021
Historique:
received: 23 10 2020
accepted: 29 12 2020
entrez: 21 1 2021
pubmed: 22 1 2021
medline: 25 8 2021
Statut: epublish

Résumé

The properties of semi-elemental enteral nutrition might theoretically improve gastrointestinal tolerance in brain-injured patients, known to suffer gastroparesis. The purpose of this study was to compare the efficacy and tolerance of a semi-elemental versus a polymeric formula for enteral nutrition (EN) in brain-injured critically ill patients. Prospective, randomized study including brain-injured adult patients [Glasgow Coma Scale (GCS) ≤ 8] with an expected duration of mechanical ventilation > 48 h. an enteral semi-elemental (SE group) or polymeric (P group) formula. EN was started within 36 h after admission to the intensive care unit and was delivered according to a standardized nurse-driven protocol. The primary endpoint was the percentage of patients who received both 60% of the daily energy goal at 3 days and 100% of the daily energy goal at 5 days after inclusion. Tolerance of EN was assessed by the rate of gastroparesis, vomiting and diarrhea. Respectively, 100 and 95 patients were analyzed in the SE and P groups: Age (57[44-65] versus 55[40-65] years) and GCS (6[3-7] versus 5[3-7]) did not differ between groups. The percentage of patients achieving the primary endpoint was similar (46% and 48%, respectively; relative risk (RR) [95% confidence interval (CI)] = 1.05 (0.78-1.42); p = 0.73). The mean daily energy intake was, respectively, 20.2 ± 6.3 versus 21.0 ± 6.5 kcal/kg/day (p = 0.42). Protein intakes were 1.3 ± 0.4 versus 1.1 ± 0.3 g/kg/day (p < 0.0001). Respectively, 18% versus 12% patients presented gastroparesis (p = 0.21), and 16% versus 8% patients suffered from diarrhea (p = 0.11). No patient presented vomiting in either group. Semi-elemental compared to polymeric formula did not improve daily energy intake or gastrointestinal tolerance of enteral nutrition. EudraCT/ID-RCB 2012-A00078-35 (registered January 17, 2012).

Sections du résumé

BACKGROUND
The properties of semi-elemental enteral nutrition might theoretically improve gastrointestinal tolerance in brain-injured patients, known to suffer gastroparesis. The purpose of this study was to compare the efficacy and tolerance of a semi-elemental versus a polymeric formula for enteral nutrition (EN) in brain-injured critically ill patients.
METHODS
Prospective, randomized study including brain-injured adult patients [Glasgow Coma Scale (GCS) ≤ 8] with an expected duration of mechanical ventilation > 48 h.
INTERVENTION
an enteral semi-elemental (SE group) or polymeric (P group) formula. EN was started within 36 h after admission to the intensive care unit and was delivered according to a standardized nurse-driven protocol. The primary endpoint was the percentage of patients who received both 60% of the daily energy goal at 3 days and 100% of the daily energy goal at 5 days after inclusion. Tolerance of EN was assessed by the rate of gastroparesis, vomiting and diarrhea.
RESULTS
Respectively, 100 and 95 patients were analyzed in the SE and P groups: Age (57[44-65] versus 55[40-65] years) and GCS (6[3-7] versus 5[3-7]) did not differ between groups. The percentage of patients achieving the primary endpoint was similar (46% and 48%, respectively; relative risk (RR) [95% confidence interval (CI)] = 1.05 (0.78-1.42); p = 0.73). The mean daily energy intake was, respectively, 20.2 ± 6.3 versus 21.0 ± 6.5 kcal/kg/day (p = 0.42). Protein intakes were 1.3 ± 0.4 versus 1.1 ± 0.3 g/kg/day (p < 0.0001). Respectively, 18% versus 12% patients presented gastroparesis (p = 0.21), and 16% versus 8% patients suffered from diarrhea (p = 0.11). No patient presented vomiting in either group.
CONCLUSION
Semi-elemental compared to polymeric formula did not improve daily energy intake or gastrointestinal tolerance of enteral nutrition.
TRIAL REGISTRATION
EudraCT/ID-RCB 2012-A00078-35 (registered January 17, 2012).

Identifiants

pubmed: 33472680
doi: 10.1186/s13054-020-03456-7
pii: 10.1186/s13054-020-03456-7
pmc: PMC7818740
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

31

Subventions

Organisme : Howard Hughes Medical Institute
Pays : United States

Références

Clin Nutr. 2019 Feb;38(1):48-79
pubmed: 30348463
JPEN J Parenter Enteral Nutr. 2006 Jan-Feb;30(1):1-5
pubmed: 16387891
Crit Care. 2017 Jun 10;21(1):140
pubmed: 28599662
Clin Nutr. 2006 Apr;25(2):210-23
pubmed: 16697087
Am J Physiol. 1994 Nov;267(5 Pt 2):R1163-7
pubmed: 7977841
Crit Care. 2018 Jun 12;22(1):156
pubmed: 29895309
Clin Nutr. 2016 Dec;35(6):1315-1322
pubmed: 26949198
World J Gastrointest Pharmacol Ther. 2016 May 6;7(2):306-19
pubmed: 27158547
Gastroenterology. 1981 May;80(5 pt 1):922-7
pubmed: 7202976
World J Gastroenterol. 2003 Dec;9(12):2776-81
pubmed: 14669332
Crit Care. 2018 Dec 4;22(1):330
pubmed: 30514322
Crit Care. 2019 Jan 14;23(1):12
pubmed: 30642377
Neurocrit Care. 2017 Oct;27(2):276-286
pubmed: 28004327
Crit Care. 2018 Sep 22;22(1):230
pubmed: 30241491
Crit Care Med. 2009 May;37(5):1757-61
pubmed: 19373044
Crit Care. 2018 Oct 25;22(1):261
pubmed: 30360760
Br J Neurosurg. 2011 Feb;25(1):2-8
pubmed: 21323401
Nutr Clin Pract. 2018 Jun;33(3):419-425
pubmed: 29665145
J Clin Endocrinol Metab. 2006 Jun;91(6):2062-7
pubmed: 16537685
Clinicoecon Outcomes Res. 2018 Jun 05;10:293-300
pubmed: 29892200
Crit Care. 2011;15(6):234
pubmed: 22136305
Nutrients. 2018 Oct 07;10(10):
pubmed: 30301241
Gut. 1987 Jun;28(6):681-7
pubmed: 3114056
Metab Brain Dis. 2018 Oct;33(5):1755-1760
pubmed: 30014176
Surg Gynecol Obstet. 1992 Mar;174(3):181-8
pubmed: 1542832
J Neurotrauma. 2008 Dec;25(12):1415-31
pubmed: 19118457
Crit Care. 2017 Sep 5;21(1):232
pubmed: 28874199
Crit Care. 2016 Jan 07;20:6
pubmed: 26738550
Anaesth Crit Care Pain Med. 2018 Feb;37(1):83-98
pubmed: 29155054
Clin Nutr. 2017 Jun;36(3):706-709
pubmed: 27161892
Nutrition. 2011 Apr;27(4):440-4
pubmed: 21167685
Crit Care. 2019 Sep 18;23(1):318
pubmed: 31533772
Anaesth Crit Care Pain Med. 2020 Dec;39(6):883-885
pubmed: 33130015
JPEN J Parenter Enteral Nutr. 2009 Nov-Dec;33(6):646-55
pubmed: 19892902
Nutr Clin Pract. 2017 Apr;32(1_suppl):142S-151S
pubmed: 28388374
Crit Care. 2019 Nov 21;23(1):368
pubmed: 31752979
JPEN J Parenter Enteral Nutr. 1997 May-Jun;21(3):162-7
pubmed: 9168369

Auteurs

Laurent Carteron (L)

Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, 3 bvd Alexander Fleming, 25000, Besancon, France. lcarteron@chu-besancon.fr.
EA3920, University of Franche Comté, Besancon, France. lcarteron@chu-besancon.fr.

Emmanuel Samain (E)

Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, 3 bvd Alexander Fleming, 25000, Besancon, France.
EA3920, University of Franche Comté, Besancon, France.

Hadrien Winiszewski (H)

EA3920, University of Franche Comté, Besancon, France.
Medical Intensive Care Unit, University Hospital of Besancon, Besancon, France.

Gilles Blasco (G)

Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, 3 bvd Alexander Fleming, 25000, Besancon, France.

Anne-Sophie Balon (AS)

Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, 3 bvd Alexander Fleming, 25000, Besancon, France.

Camille Gilli (C)

Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, 3 bvd Alexander Fleming, 25000, Besancon, France.

Gael Piton (G)

EA3920, University of Franche Comté, Besancon, France.
Medical Intensive Care Unit, University Hospital of Besancon, Besancon, France.

Gilles Capellier (G)

EA3920, University of Franche Comté, Besancon, France.
Medical Intensive Care Unit, University Hospital of Besancon, Besancon, France.

Sebastien Pili-Floury (S)

Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, 3 bvd Alexander Fleming, 25000, Besancon, France.
EA3920, University of Franche Comté, Besancon, France.

Guillaume Besch (G)

Department of Anesthesiology and Intensive Care Medicine, University Hospital of Besancon, 3 bvd Alexander Fleming, 25000, Besancon, France.
EA3920, University of Franche Comté, Besancon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH